Document:

Exhibit

PRIVILEGED & CONFIDENTIAL    
    

Ex. 10.26
CONSULTING AGREEMENT
Alexandra O. Haden (“Haden”) and MiMedx Group, Inc. (“Company”) hereby enter into this Consulting Agreement (“Agreement”) dated and effective as of August 12, 2019 and agree as follows:
1.Resignation from Employment.  Haden has resigned from her employment with Company, as well as from any and all officer positions that Haden held with Company and its affiliates effective at the close of business on August 12, 2019 (the “Separation Date”).    Company has accepted such resignations.  
2.Consulting Period.  
a.    Company and Haden agree that in her position as General Counsel and Secretary of Company, Haden developed detailed knowledge of Company’s business, strategies, and legal affairs (including without limitation with respect to Company’s Board of Directors and certain ongoing Company litigation matters), and that Company now desires that Haden provide consulting services to Company to continue to assist it with such matters.  Accordingly, subject to the terms and conditions of this Agreement, and provided that Haden signs and returns this Agreement to Company within 21 days of her receipt thereof, complies with the terms of this Agreement, and does not revoke this Agreement in accordance with Section 13 below, Haden will provide to Company consulting services as Company requests from time to time (the “Consulting Services”),up to 40 hours per calendar month, on a non-exclusive basis as an independent contractor for a period (the “Consulting Period”) beginning on August 13, 2019 and ending on February 29, 2020 (the “Consulting End Date,” unless Company terminates the Consulting Period prior to February 29, 2020 pursuant to Section 2(d) below, in which case the Consulting End Date will be the effective date of such termination).  Such Consulting Services shall include, but shall not be limited to, the matters and deliverables set forth in Exhibit A.  During the Consulting Period, Haden will inform Lee Ann Lawson, Company’s Vice President, Human Resources, not less than once every other week of the progress and results of the Consulting Services.  Haden will perform all Consulting Services diligently, in the best interests of Company and to the best of her professional ability and judgment.  Haden will not enter into any agreement or other obligations on behalf of Company without the express prior written consent of Company’s Chief Executive Officer.  
b.    Subject to the terms of this Agreement, Company will pay Haden a consulting fee during the Consulting Period at the rate of $8,000 per month (the “Consulting Fee”), payable monthly without any deductions or withholdings, which Haden agrees is the total amount of compensation to which she is entitled for the Consulting Services.  Haden acknowledges and agrees that she is performing Consulting Services for Company solely as an independent contractor, she will not be considered a Company employee for any purpose, and she hereby waives participation in and will not receive any employee benefits, including without limitation any participation in any Company health insurance, executive or management incentive bonus plans, equity incentive plans, or other compensation or benefit plans for Company employees or service providers, except as expressly provided in Section 2(c) below.  
c.    Company agrees that, during the Consulting Period, Haden will be providing “services” as contemplated by the MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan, the 

MiMedx Group, Inc. 2016 Equity and Cash Incentive Plan, and Haden’s applicable award agreements under such plans.
d.    Notwithstanding any other provision of this Agreement, Company may immediately terminate the Consulting Period and the Consulting Services if Haden (i) engages in any conduct that she knows or should know will or could harm the business or reputation of Company, in Company’s sole reasonable discretion, (ii) fails to perform the Consulting Services diligently, in the best interests of Company and to the best of her professional ability and judgment, to Company’s reasonable satisfaction, or (iii) otherwise breaches any provision of this Agreement or the Existing Agreements (as defined in Section 7 below).  In the event Company elects to terminate the Consulting Period pursuant to this Section 2(d), Company will pay Haden a pro rata payment for any Consulting Services rendered prior to the termination date, and no other amount; provided that, in the event of such termination, the treatment of Haden’s equity awards (whether vested or unvested) will be in accordance with Haden’s applicable award agreements under such plans.
3.Earned and Unpaid Salary and Paid Time Off (“PTO”).  Regardless of whether she signs this Agreement, Haden also will receive any earned and unpaid salary and PTO balance through the Separation Date in accordance with Company policy.  Haden’s benefits will be determined by applicable benefit plans (as in effect or amended from time to time in Company’s discretion).  Haden agrees that Company and the other Released Parties do not owe her any other amounts, including without limitation any salary, bonus, profit-sharing or incentive compensation of any kind, notice or severance pay, equity-based compensation, or other payments or benefits of any kind.
4.Additional Amount for Supplemental Release and Compliance with this Agreement.  Provided that Haden has provided the Consulting Services in accordance with Section 2 above to Company’s reasonable satisfaction through February 29, 2020, has not otherwise breached any of the terms of this Agreement, and signs and returns to Company the Supplemental Release attached as Exhibit B to this Agreement (the "Supplemental Release") within 21 days after (but not before) the Consulting End Date (without revoking it), Haden will be entitled to a special severance payment (the “Severance Amount”) in the gross aggregate amount of $476,250 (less required and authorized withholding and deductions).  Subject to the foregoing, this Severance Amount will be paid in prorated installments over a nine (9) month period in accordance with Company’s normal payroll schedule, with the first such installment commencing on the first regularly scheduled Company payday following March 28, 2020. Haden acknowledges and agrees that she would not be entitled to receive the Severance Amount but for her undertakings in this Agreement, including without limitation her satisfactory provision of the Consulting Services and her signing (and not revoking) the Supplemental Release within 21 days after (but not before) the Consulting End Date.  (For the avoidance of doubt, the Company will not be obligated to pay, and will not pay, the Severance Amount or any portion thereof unless and until Haden provides the Consulting Services through February 29, 2020 to Company’s reasonable satisfaction.)
5.Released Parties.  “Released Parties” as used in this Agreement includes:  (a) Company and its past, present, and future parents, divisions, subsidiaries, partnerships, affiliates, and other related entities, and (b) each of the foregoing entities' and persons’ past, present, and future owners, trustees, fiduciaries, administrators, shareholders, directors, officers, partners, members, associates, agents, employees, and attorneys, and (c) the predecessors, successors and assigns of each of the foregoing persons and entities.

2    

6.Release of Claims.  
a.    Haden, and anyone claiming through Haden or on Haden’s behalf, hereby waives and releases the Company and the other Released Parties with respect to any and all claims, whether currently known or unknown, that Haden now has or has ever had against the Company or any of the other Released Parties arising from or related to any act, omission, or thing occurring or existing at any time prior to or on the date on which Haden signs this Agreement.  Without limiting the foregoing, the claims waived and released by Haden hereunder include, but are not limited to:  (i) all claims arising out of or related in any way to Haden’s employment, compensation, other terms and conditions of employment, or termination from employment with the Company, including without limitation all claims for any compensation payments, bonus, severance pay, equity, or any other compensation or benefit; (ii) all claims that were or could have been asserted by Haden or on Haden’s behalf in any federal, state, or local court, commission, or agency, or under any contract, tort or other common law theory; and (iii) all claims that were or could have been asserted by Haden or on her behalf under:  (x) the Age Discrimination in Employment Act; and (y) any other federal, state, local, employment, services or other law, regulation, ordinance, constitutional provision, executive order or other source of law, including without limitation under any of the following laws, as amended from time to time:  Title VII of the Civil Rights Act of 1964, 42 U.S.C. §§ 1981 & 1981a, the Americans with Disabilities Act, the Equal Pay Act, the Employee Retirement Income Security Act, the Lilly Ledbetter Fair Pay Act of 2009, the Family and Medical Leave Act, the Genetic Information Nondiscrimination Act, the Fair Credit Reporting Act, and federal, state, and other securities laws.  Notwithstanding the foregoing, the releases and waivers in this Section 6 will not apply to any claim for unemployment or workers’ compensation, any claim, if any, to indemnification under her Indemnification Agreement dated March 1, 2015 and any applicable law, any Company by-laws, or any director and officer insurance (it being understood and agreed that this Agreement does not create or expand upon any such rights (if any) to indemnification), or any claim that by law is non-waivable. 
b.    Notwithstanding anything to the contrary in this Agreement, Haden understands that nothing contained in this Agreement limits Haden’s ability to report possible violations of law or regulation to, or file a charge or complaint with, the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the National Labor Relations Board, or any other federal, state or local governmental agency or commission (“Government Agencies”).  Haden further understands that this Agreement does not limit Haden’s ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.  Nothing in this Agreement waives or releases Haden from any obligations that Haden has as an attorney for Company or for any and all of its affiliates under applicable laws, codes, rules and canons of professional conduct and/or responsibility (as may be amended from time to time), or waives Company’s or any of its affiliates’ attorney-client, work product or other privileges with respect to any matter on which Haden worked or advised, or otherwise. 
c.    Haden confirms that she has not filed any legal or other proceeding(s) against any of the Released Parties (provided, however, that Haden need not disclose to the Company, and the foregoing confirmation does not apply to, conduct or matters described in Section 6(b) above), is the sole owner of the claims released herein, has not transferred any such claims to anyone else, and has the full right to grant the releases and agreements in this Agreement.  Haden further agrees that Haden will not at any time become a party to, or otherwise become a class- or collective-member or other similar claimant in, any class, collective, representative, 

3    

multiple-plaintiff, or other consolidated or similar action in any court or arbitration against any of the Released Parties that involves or is based upon any claim waived and released by Haden in Section 6(a) above, and will take all steps necessary to opt out of any such actions.  In the event of any complaint, charge, proceeding or other claim (collectively, “Claims”) filed with any court, other tribunal, or governmental or regulatory entity that involves or is based upon any claim waived and released in Section 6(a) above, Haden hereby waives and agrees not to accept any money or other personal relief on account of any such Claims for any actual or alleged personal injury or damages to Haden, including without limitation any costs, expenses and attorneys’ fees incurred by or on behalf of Haden.  
7.Acknowledgments, Representations, and Warranties.
a.    Haden hereby acknowledges and agrees that she remains subject to her post-employment obligations related to protection of confidential Company information, intellectual property, and other restrictive covenants, including without limitation those contained in Haden’s Employee Inventions and Assignment Agreement dated May 28, 2013, her Change in Control Severance Compensation and Restrictive Covenant Agreement dated May 20, 2016, her Non-Competition Agreement dated August 7, 2017, and her Confidentiality and Non-Solicitation Agreement dated August 7, 2017 (collectively, the “Existing Agreements”).  Haden further agrees that she remains subject to all Company policies applicable to Company employees regarding the forfeiture or recoupment of cash and/or equity compensation from current or former Company employees based on the Company’s financial restatements or other similar matters.  Haden represents and confirms that she has not engaged in any conduct with respect to the Company or her duties for the Company that violates or has violated any laws, regulations, or obligations to the Company.  Haden also acknowledges and agrees that at all times, she will remain bound by, and will comply with, any and all applicable laws, codes, rules and canons of professional conduct and/or responsibility (as may be amended from time to time) that are applicable to her and/or her prior professional relationship with Company and any and all of its affiliates as an attorney for Company and its affiliates, including without limitation preserving Company’s and its affiliates’ attorney-client, work product and other applicable privileges.  Further, during the Consulting Period, Haden will not perform services for or enter into an engagement with any entity that could create a conflict of interest for Haden or could result in the breach of any of this Consulting Agreement, the Existing Agreements, or any other prior obligation Haden has to Company without Company’s express prior written consent.  Haden agrees that she has no present or future right to employment with Company or any of the other Released Parties and will not apply for employment with any of them.
b.    Except as provided in Section 6(b) above, and without limiting or otherwise affecting Haden’s obligations under Section 2 of this Agreement, following the Separation Date, Haden will reasonably cooperate in any administrative, investigative, litigation or other legal matter(s) involving the Company or any of the other Released Parties and which in any way relate to or involve Haden’s employment with or other services to the Company.  Haden’s obligation to cooperate hereunder will include, without limitation, meeting and conferring with such persons at such times and in such places as the Company and the other Released Parties may reasonably require (including without limitation by telephone, video conference, or other remote means of communication), and giving truthful evidence and truthful testimony and executing and delivering to the Company and any of the other Released Parties any truthful papers reasonably requested by any of them.  Haden will be reimbursed for reasonable out-of-pocket expenses that Haden incurs in rendering cooperation after the Separation Date pursuant to this Agreement, in accordance 

4    

with the Company’s business expense policies then in effect and any associated reasonable attorney’s fees, in connection with the existing indemnification agreement.
c.    Haden hereby represents and warrants that: (i) any subsequent employment she has with, or responsibilities for, any other employer or other entity after the Separation Date will not violate any of her post-separation obligations to Company in the  Existing Agreements, this Agreement, or otherwise; (ii) she will not use or disclose to Company or its affiliates any confidential or proprietary information of any other person or entity (including, but not limited to any subsequent employer) in the provision of the Consulting Services; (iii) her  provision of the Consulting Services will not violate, and is not otherwise restricted by, any obligation she may have to any other person or entity, including any subsequent employer; and (iv) she has disclosed the fact, anticipated duration, and time commitment associated with the Consulting Services to her new employer and that her new employer has consented to her providing the Consulting Services as contemplated by this Agreement. 
8.Return of Property.  Haden acknowledges and confirms that she has returned or will promptly return all property of Company and the other Released Parties that is in her possession, custody, or control, including without limitation any and all documents and other information that reflect or contain any Company confidential or proprietary information, cell phones and other mobile devices, computers, credit cards, and other equipment and materials furnished to her by Company; provided, however that Haden will be entitled to retain during the Consulting Period such property and/or equipment as Company deems necessary for her performance of the Consulting Services but will return all such property upon the earlier of Company’s request and the Consulting End Date.
9.Non-Disparagement.  Except as otherwise provided in Section 6(b), Haden will refrain from all conduct, verbal or otherwise, that disparages or damages the reputation, goodwill, or standing in the community of the Company, any of the other Released Parties, clients, customers, or any of the Company’s past, present, or prospective products, services, or other lines of business, and represents that she has not engaged in any such conduct; provided that nothing herein will prohibit Haden from giving truthful testimony or evidence to a governmental entity, or if properly subpoenaed or otherwise required to do so under applicable law.  Company agrees that it will instruct the individuals who hold the positions of Chief Executive Officer and Chief Financial Officer, as well as, 16 b Officers and SVP, Human Resources, to refrain from all conduct, verbal or otherwise, that disparages or damages the reputation, goodwill, or standing in the community of Haden; provided that nothing herein will prohibit such individuals from giving truthful testimony or evidence to a governmental entity, or if properly subpoenaed or otherwise required to do so under applicable law.
10.Representation Re: “Ineligible Persons”. Company complies with all Federal and State laws and regulations, including the requirement not to contract with “Ineligible Persons.” An “Ineligible Person” is any individual or entity who: (i) is currently excluded, suspended, debarred or otherwise ineligible to participate in the Federal health care programs (as defined below); or (ii) has been convicted of a criminal offense related to the provision of health care items or services and has not been reinstated in the Federal health care programs after a period of exclusion, suspension, debarment or ineligibility. Haden hereby warrants and represents that neither Haden nor any individual employed by Haden is an Ineligible Person. Haden agrees to disclose to Company immediately any event that makes Haden or any individual employed by Haden an Ineligible Person. Haden agrees to provide access to, permit audit of, and provide copies of records and other information to the U.S. Department of Justice, the Secretary of the U.S. Department of Health and 

5    

Human Services, the U.S. Comptroller General, CMS and such other officials entitled by law or under government-funded programs (collectively, “Government Officials”) as may be necessary for compliance by Company with the provisions of all state and federal laws and contractual requirements governing Company, including, but not limited to, the Medicare program.  For purposes of this Agreement, the term “Federal health care program” shall have the meaning ascribed to it in 42 U.S.C. § 1320a-7b(f).
11.No Admission.  Nothing in this Agreement is intended to or will be construed as an admission by Company or any of the other Released Parties that any of them violated any law, breached any obligation or otherwise engaged in any improper or illegal conduct with respect to Haden or otherwise.  The Released Parties expressly deny any such illegal or wrongful conduct.
12.Remedies.  Haden and Company agree that a breach of Section 7(a), Section 7(b), or Sections 8-10 of this Agreement by Haden will result in irreparable damages and harm to Company and that Company will be without an adequate remedy at law in the event of such breach.  As a result, Haden agrees that Company may, in addition to any other remedies available to it, institute and prosecute proceedings in any court of competent jurisdiction to enjoin Haden from violating such provisions of this Agreement and that, in any such proceedings, Haden will not assert that Company has an adequate remedy at law for the breach by Haden of such provisions.
13.Haden understands and agrees that:  (a) this is the full and final release of all claims against the Released Parties through the date she signs this Agreement; (b) she knowingly and voluntarily releases claims hereunder for valuable consideration; (c) she hereby is and has been advised of her right to have her attorney review this Agreement (at her cost) before signing it; (d) she has 21 days to consider whether to sign this Agreement; and (e) she may, at her sole option, revoke this Agreement upon written notice delivered to Lee Ann Lawson, Company’s Vice President, Human Resources, within 7 days after signing it.  This Agreement will not become effective or enforceable until this 7-day period has expired and will be void if Haden revokes it. 
14.Additional Provisions.  This Agreement embodies the entire agreement of the parties regarding the matters described herein and supersedes any and all prior and/or contemporaneous agreements, oral or written, between the parties regarding such matters, provided that the Existing Agreements will continue in full force and effect in accordance with their terms.  Haden acknowledges that no promises or representations other than those set forth in this Agreement have been made to her to induce her to sign this Agreement, and that Haden only has relied on promises expressly stated herein.  This Agreement is governed by the internal laws of the State of Georgia, and may be modified only by a writing signed by all parties.  The waiver by either party of a breach of any term or provision of this Agreement must be in writing signed by such party in order to be binding and, further, will not operate or be construed as a waiver of a subsequent breach of the same provision by any party or of the breach of any other term or provision of this Agreement.  This Agreement is enforceable by the Company and its affiliates and may be assigned or transferred by the Company to, and will be binding upon and inure to the benefit of, any parent or other affiliate of the Company or any person which at any time, whether by merger, purchase, or otherwise, acquires all or substantially all of the assets, stock or business of the Company or of any division thereof.  Haden may not assign any of Haden’s rights or obligations under this Agreement.  If any restriction(s) herein is found to be unenforceable by a court of competent jurisdiction, the parties agree that any such restriction(s) may be modified or limited so that it or they may then be enforced to the fullest extent possible.  The provisions of this Agreement 

6    

are severable if a court of competent jurisdiction finds any of them unenforceable (after any modification or limitation under the foregoing).  
15.Tax Matters.  
a.    Haden and the Company agree that any Consulting Fees will be reported on an IRS Form 1099, and that the Severance Amount  will be reported on an IRS Form W-2.  Haden acknowledges and agrees that she is and will be solely responsible for the payment of any and all applicable federal, state, local, and other taxes relating to any Consulting Fees paid pursuant to Section 2 of this Agreement.  Haden further agrees to indemnify, defend, and hold harmless Company and the other Indemnified Parties for and against any and all federal, state, local, or other tax liability (including without limitation, liability for back withholding, penalties, interest, and attorneys' fees) incurred by any of the Indemnified Parties (as defined below) relating in any way to the Consulting Fees.
b.    All payments and other benefits provided under this Agreement will be subject to applicable withholdings and deductions in accordance with applicable law.  It is intended that any amounts payable under this Agreement will be exempt from or comply with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and treasury regulations relating thereto, so as not to subject Haden to the payment of any interest and tax penalty which may be imposed under Section 409A of the Code, and this Agreement will be interpreted and construed accordingly; provided, however, that the Company and the other Released Parties will not be responsible for any taxes, penalties, interest or other losses or expenses incurred by Haden due to any failure to comply with Section 409A of the Code.  The timing of the payments or benefits provided herein may be modified to so comply with Section 409A of the Code.  All references in this Agreement to Haden’s termination of employment and to the Separation Date will mean a separation from service within the meaning of Section 409A of the Code, to the extent necessary under 409A.  Each payment under this Agreement as a result of the separation of Haden’s service will be considered a separate payment for purposes of Section 409A of the Code.  Notwithstanding any other provision in this Agreement, if on the date of Haden’s separation from service (as defined in Section 409A of the Code) (i) the Company is a publicly traded corporation and (ii) Haden is a “specified employee,” as defined in Section 409A of the Code, then to the extent any amount payable under this Agreement upon Haden’s separation from service constitutes the payment of nonqualified deferred compensation, within the meaning of Section 409A of the Code, that under the terms of this Agreement would be payable prior to the six (6) month anniversary of Haden’s separation from service, such payment will be delayed until the earlier to occur of (x) the first day of the seventh month following Haden’s separation from service or (y) the date of Haden’s death.  Any reimbursement payable to Haden pursuant to this Agreement will be conditioned on the submission by Haden of all expense reports reasonably required by the Company under any applicable expense reimbursement policy, and will be paid to Haden within thirty (30) days following receipt of such expense reports, but in no event later than the last day of the calendar year following the calendar year in which Haden incurred the reimbursable expense.  Any amount of expenses eligible for reimbursement or in-kind benefit provided during a calendar year will not affect the amount of expenses eligible for reimbursement or in-kind benefit to be provided during any other calendar year.  The right to reimbursement or to an in-kind benefit pursuant to this Agreement will not be subject to liquidation or exchange for any other benefit.
16.Counterparts.  This Agreement may be executed in one or more counterparts, each of which will be considered an original, and all of which taken together will be considered one and 

7    

the same instrument. This Agreement may be executed by .pdf signatures and a .pdf signature will constitute an original for all purposes.
        

8    

THE PARTIES STATE THAT THEY HAVE READ THE FOREGOING, UNDERSTAND EACH OF ITS TERMS, AND INTEND TO BE BOUND THEREBY:

	
		
	ALEXANDRA O. HADEN

/s/ Alexandra O. Haden _ _________

Date:  8/23/2019

	MIMEDX GROUP, INC.

/s/ Timothy Wright _ _________

Title: CEO

Date:  8-27-2019

9    

EXHIBIT A

DESCRIPTION OF CONSULTING SERVICES

In addition to such other services as MiMedx Group, Inc. (“Company”) may request from time to time, the Consulting Services shall include the following matters, which Haden shall be responsible for completing and/or assistance with, in a manner that meets Company’s reasonable satisfaction, during the Consulting Period:

		
	•
	Preparation and completion of meeting minutes related to the meetings of Company’s Board of Directors and committees thereof between March 1, 2015 and April 12, 2019.

		
	•
	Availability to discuss various Board of Director initiatives or special committees and or general questions regarding previous Board activities

		
	•
	Available for inquiries or questions related to any existing general case and/or litigation matters including but not limited to pending SEC and DOJ government investigations and pending shareholder derivative and class action lawsuits.

10    

EXHIBIT B -- SUPPLEMENTAL RELEASE
Alexandra O. Haden ("Haden") and MiMedx Group, Inc. (“Company”) hereby enter into this Supplemental Release ("Release") in accordance with the Consulting Agreement between Company and Haden dated as of August 12, 2019 (the "Agreement").  Capitalized terms not expressly defined in this Release will have the meanings set forth in the Agreement:
1.    Haden understands and agrees that Haden’s execution of this Release within 21 days after (but not before) the Consulting End Date (without revoking it) is among the conditions precedent to Company’s obligation to provide the Severance Amount set forth in Section 4 of the Agreement.  Company will provide such benefit in accordance with the terms of the Agreement once the conditions set forth therein and in this Release have been met.
2.    "Released Parties" as used in this Release includes:  (a) Company and its past, present, and future parents, divisions, subsidiaries, partnerships, affiliates, and other related entities; (b) each of the foregoing entities' and persons’ past, present, and future owners, trustees, fiduciaries, administrators, shareholders, directors, officers, partners, members, associates, agents, employees, and attorneys; and (c) the predecessors, successors and assigns of each of the foregoing persons and entities.
3.    Haden and anyone claiming through her or on her behalf hereby waive and release Company and the other Released Parties with respect to any and all claims, whether currently known or unknown, that Haden now has or has ever had against Company or any of the other Released Parties arising from or related to any act, omission, or thing occurring or existing at any time prior to or on the date on which she signs this Release.  Without limiting the foregoing, the claims waived and released by Haden hereunder include, but are not limited to, all claims under the Age Discrimination in Employment Act; all claims under any other federal, state, local, employment, services or other law, regulation, ordinance, constitutional provision, executive order or other source of law; all claims arising out of Haden’s employment and the Consulting Services, compensation, other terms and conditions of employment or the Consulting Services, or termination from employment or the Consulting Services; all claims for discrimination, harassment, retaliation and failure to accommodate; and all contract, tort and other common law claims, including without limitation all claims for breach of contract (oral, written or implied), wrongful termination, defamation, invasion of privacy, infliction of emotional distress, tortious interference, fraud, estoppel and unjust enrichment.  Notwithstanding the foregoing, the releases and waivers in this Section 3 will not apply to any claim for unemployment or workers’ compensation, any claim, if any, to indemnification under her Indemnification Agreement dated March 1, 2015, and any applicable law, any Company by-laws, or any director and officer insurance (it being understood and agreed that this Agreement does not create or expand upon any such rights (if any) to indemnification).  
4.    Haden confirms that she has not filed any legal or other proceeding(s) against any of the Released Parties, is the sole owner of and has not transferred the claims released herein, and has the full right to grant the releases and agreements in this Release.  In the event of any further proceedings based upon any released matter, none of the Released Parties will have any further monetary or other obligation of any kind to Haden, and Haden hereby waives any such monetary or other recovery. 
5.    Haden understands and agrees that:  (a) this is the full and final release of all claims against the Released Parties through the date she signs this Release; (b) she knowingly and voluntarily releases claims hereunder for valuable consideration; (c) she hereby is and has been advised of her right to have her attorney review this Release (at her cost) before signing it; (d) she has 21 days to consider whether to sign this Release; and (e) she may, at her sole option, revoke this Release upon written notice delivered to Lee Ann Lawson, Company’s Vice President, Human Resources within 7 days after signing it.  This Release will not become effective or enforceable until this 7-day period has expired and will be void if Haden revokes it. 
6.    Except as required by law, Haden will not disclose the existence or terms of this Release to anyone except her accountants, attorneys and spouse, provided that each such person will be bound by this confidentiality provision and Haden will ensure such confidentiality.  Nothing in this Release is intended to or will be construed as an admission by any of the Released Parties that any of them violated any law, breached any obligation or otherwise engaged in any improper or illegal conduct with respect to Haden or otherwise.  The Released Parties expressly deny any such illegal or wrongful conduct.  This Release, the Agreement, and the Existing Agreements are the entire agreement of the parties regarding the matters described in such agreements and supersede any and all prior and/or contemporaneous agreements, oral or written, between the parties regarding such matters.  This Release is governed by Georgia law, may be signed in counterparts, and may be modified only by a writing signed by all parties.

THE PARTIES STATE THAT THEY HAVE READ AND UNDERSTAND THE FOREGOING AND KNOWINGLY AND VOLUNTARILY INTEND TO BE BOUND THERETO:
ALEXANDRA O. HADEN                MIMEDX GROUP, INC.
______________________________            By:___________________________
Title: _________________________      
Date:_________________________            Date:_________________________ 

2Exhibit
10.1

 

VOTING AND SUPPORT AGREEMENT

 

This Voting and Support Agreement, dated
as of March 16, 2020 (this “Agreement”), among Alligator Zebra Holdings, Inc., a Delaware corporation (“Parent”),
and the stockholder of Zyla Life Sciences, a Delaware corporation (the “Company”) listed on Schedule A
hereto (the “Stockholder”).

 

RECITALS

 

WHEREAS,
concurrently herewith, Parent, Zebra Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger
Sub”), Assertio Therapeutics, Inc., a Delaware corporation (“Assertio”), and the Company are
entering into an Agreement and Plan of Merger (the “Merger Agreement”; capitalized terms used but not defined
in this Agreement shall have the meanings ascribed to them in the Merger Agreement), pursuant to which (and subject to the terms
and conditions set forth therein) Merger Sub will merge with and into the Company, with the Company continuing as the surviving
corporation in the merger and as a wholly-owned subsidiary of Parent (the “Merger”);

 

WHEREAS, Stockholder is the record or “beneficial
owner” (within the meaning of Rule 13d-3 under the Exchange Act) of shares of common stock, par value $0.001 per
share, of the Company (“Shares”) as set forth on Schedule A hereto (with respect to each Stockholder,
the “Covered Shares”;

 

WHEREAS, as a condition and material inducement
to Parent, Assertio, and Merger Sub’s willingness to enter into the Merger Agreement and to proceed with the transactions
contemplated thereby, including the Merger, Parent has required Stockholder to enter into this Agreement; and

 

WHEREAS, the Stockholder acknowledges that
Parent, Assertio, and Merger Sub are entering into the Merger Agreement in reliance on the representations, warranties, covenants
and other agreements of the Stockholder set forth in this Agreement and would not enter into the Merger Agreement if the Stockholder
did not enter into this Agreement.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the
foregoing and the mutual covenants and agreements herein contained, and intending to be legally bound hereby, Parent and the Stockholders
hereby agree as follows:

 

1.                 
Agreement to Vote. Prior to the Termination Date (as defined herein), subject to the terms and conditions set forth
herein, the Stockholder irrevocably and unconditionally agrees that it shall at any meeting of the stockholders of the Company
(whether annual or special and whether or not an adjourned or postponed meeting) (a “Stockholder Meeting”) called
for the purpose of considering the Merger or any Acquisition Proposal, however called, or in connection with any written consent
of stockholders of the Company in connection with the approval of the Merger or any Acquisition Proposal:

 

    

     

    

 

(a)              
when a Stockholder Meeting is held, appear at such meeting or otherwise cause the Covered Shares to be counted as present
thereat for the purpose of establishing a quorum, and respond to each request by the Company for written consent, if any, and

 

(b)              
vote, or cause to be voted at such meeting (or validly execute and return and cause such consent to be granted with respect
to), all Covered Shares:

 

(i)            
in favor of the Merger, the adoption of the Merger Agreement and any other matters necessary for consummation of the Merger
and the other transactions contemplated in the Merger Agreement, and

 

(ii)          
against:

 

(A)            
any Acquisition Proposal; and

 

(B)             
any other action that would reasonably be expected to impede, interfere with, delay, postpone or adversely affect the Merger
or any of the transactions contemplated by the Merger Agreement or this Agreement or any transaction that results in a breach in
any material respect of any covenant, representation or warranty or other obligation or agreement of the Company under the Merger
Agreement.

 

2.                 
Grant of Irrevocable Proxy; Appointment of Proxy.

 

(a)              
The Stockholder hereby grants to, and appoints, Parent, the executive officers of Parent, and any other designee of Parent,
each of them individually, the Stockholder’s irrevocable (until the Termination Date) proxy and attorney-in-fact (with full
power of substitution) to vote the Covered Shares as indicated in Section 1. The Stockholder intends this proxy to be irrevocable
(until the Termination Date) and coupled with an interest and will take such further action or execute such other instruments as
may be reasonably necessary to effectuate the intent of this proxy and hereby revokes any proxy previously granted by the Stockholder
with respect to the Covered Shares.

 

(b)              
The proxy granted in this Section 2 shall automatically expire upon the termination of this Agreement.

 

3.                 
No Inconsistent Agreements. The Stockholder hereby represents, covenants and agrees that, except as contemplated
by this Agreement, the Stockholder: (a) has not entered into, and shall not enter into at any time prior to the Termination
Date, any tender, voting or other similar agreement or arrangement, or voting trust with respect to any Covered Shares and (b) has
not granted, and shall not grant at any time prior to the Termination Date, a proxy or power of attorney with respect to any Covered
Shares, in either case, which is inconsistent with the Stockholder’s obligations pursuant to this Agreement.

 

4.                  Release
of Covered Shares. Notwithstanding anything in this Agreement to the contrary, in the event of a Company Adverse
Recommendation Change in accordance with, and as permitted by, Section 6.2 of the Merger Agreement, the obligation of the
Stockholder to vote the Covered Shares in the manner pursuant to Section 1(b) and to grant a proxy to vote the Covered Shares
pursuant to Section 2 in a manner consistent with Section 1(b) shall terminate and expire and any proxy theretofore granted
to vote the Covered Shares pursuant to Section 2 shall be null and void.

 

    2

     

    

 

5.                 
Termination. This Agreement shall terminate upon the earliest of: (a) the Effective Time, (b) the termination
of the Merger Agreement in accordance with its terms, (c) the release of the Covered Shares pursuant to Section 4 hereof, (d)
unless its obligations hereunder are reconfirmed by Stockholder, any amendment to the terms of the Merger or the Merger Agreement
which has the effect of extending the Outside Date beyond the period set forth in the Merger Agreement, as entered into on the
date hereof, or which affects the terms of the Alligator Reorganization or the Merger in a manner adverse to the holders of Company
Common Stock, and (e) written notice of termination of this Agreement by Parent to the Stockholder (such earliest date being
referred to herein as the “Termination Date”); provided, that the provisions set forth in Sections 13
to 27 shall survive the termination of this Agreement; provided  further, that any liability incurred by any
party hereto as a result of a breach of a term or condition of this Agreement prior to such termination shall survive the termination
of this Agreement.

 

6.                 
Representations and Warranties of Stockholder. The Stockholder hereby represents and warrants to Parent as follows:

 

(a)              
The Stockholder is the record or beneficial owner of, and has good and valid title to, the Covered Shares, free and clear
of Liens other than as created by this Agreement. The Stockholder has sole voting power, sole power of disposition, sole power
to demand appraisal rights and sole power to agree to all of the matters set forth in this Agreement, in each case with respect
to all of such Covered Shares, with no limitations, qualifications or restrictions on such rights, subject to applicable federal
securities laws and the terms of this Agreement. The Covered Shares are not subject to any voting trust agreement or other Contract
to which the Stockholder is a party restricting or otherwise relating to the voting or Transfer (as defined below) of the Covered
Shares. The Stockholder has not appointed or granted any proxy or power of attorney that is still in effect with respect to any
Covered Shares, except as contemplated by this Agreement.

 

(b)               The
Stockholder is duly organized, validly existing and in good standing under the laws of the jurisdiction of its formation and
has all requisite power and authority to execute and deliver this Agreement and to perform its obligations hereunder; each
the Stockholder who is a natural person has full legal power and capacity to execute and deliver this Agreement and to
perform the Stockholder’s obligations hereunder. The execution, delivery and performance of this Agreement by the
Stockholder, the performance by the Stockholder of its obligations hereunder and the consummation by the Stockholder of the
transactions contemplated hereby have been duly and validly authorized by the Stockholder and no other actions or proceedings
on the part of the Stockholder are necessary to authorize the execution and delivery by the Stockholder of this Agreement,
the performance by the Stockholder of its obligations hereunder or the consummation by the Stockholder of the transactions
contemplated hereby. This Agreement has been duly and validly executed and delivered by the Stockholder and, assuming due
authorization, execution and delivery by Parent, constitutes a legal, valid and binding obligation of the Stockholder,
enforceable against the Stockholder in accordance with its terms, except as enforcement may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general
principles of equity (regardless of whether considered in a proceeding in equity or at law).

 

    3

     

    

 

(c)              
Except for the applicable requirements of the Exchange Act, (i) no filing with, and no permit, authorization, consent
or approval of, any Governmental Authority is necessary on the part of the Stockholder for the execution, delivery and performance
of this Agreement by the Stockholder or the consummation by the Stockholder of the transactions contemplated hereby and (ii) neither
the execution, delivery or performance of this Agreement by the Stockholder nor the consummation by the Stockholder of the transactions
contemplated hereby nor compliance by the Stockholder with any of the provisions hereof shall (A) conflict with or violate,
any provision of the organizational documents of the Stockholder, (B) result in any breach or violation of, or constitute
a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any rights
of termination, amendment, acceleration or cancellation of, or result in the creation of a Lien on such property or asset of the
Stockholder pursuant to, any Contract to which the Stockholder is a party or by which the Stockholder or any property or asset
of the Stockholder is bound or affected or (C) violate any order, writ, injunction, decree, statute, rule or regulation applicable
to the Stockholder or any of the Stockholder’s properties or assets except, in the case of clause (B) or (C), for breaches,
violations or defaults that would not, individually or in the aggregate, materially impair the ability of the Stockholder to perform
its obligations hereunder.

 

(d)              
There is no action, suit, investigation, complaint or other proceeding pending against any the Stockholder or, to the knowledge
of the Stockholder, any other Person or, to the knowledge of the Stockholder, threatened against any Stockholder or any other Person
that restricts or prohibits (or, if successful, would restrict or prohibit) the exercise by Parent of its rights under this Agreement
or the performance by any party of its obligations under this Agreement.

 

(e)              
Except as provided in the Merger Agreement or the Company Disclosure Letter, no broker, finder or investment banker is entitled
to any brokerage, finder’s or other fee or commission in connection with the transactions contemplated by the Merger Agreement
or this Agreement based upon arrangements made by or on behalf of the Stockholder.

 

(f)               
The Stockholder understands and acknowledges that Parent and Merger Sub are entering into the Merger Agreement in reliance
upon the Stockholder’s execution and delivery of this Agreement and the representations and warranties of the Stockholder
contained herein.

 

7.                 
Certain Covenants of Stockholder. The Stockholder, hereby covenants and agrees as follows:

 

(a)              
Prior to the Termination Date, the Stockholder shall not, and shall not authorize or permit any of its Subsidiaries or Representatives,
directly or indirectly, to:

 

(i)                
solicit, initiate, endorse, encourage or facilitate the making by any Person (other than the other parties to the Merger
Agreement) of any Acquisition Proposal;

 

    4

     

    

 

(ii)              
enter into, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any Person any
information or data with respect to, or otherwise cooperate in any way with, any Acquisition Proposal;

 

(iii)            
execute or enter into any Contract constituting or relating to any Acquisition Proposal, or approve or recommend or propose
to approve or recommend any Acquisition Proposal or any Contract constituting or relating to any Acquisition Proposal (or authorize
or resolve to agree to do any of the foregoing actions); or

 

(iv)            
make, or in any manner participate in a “solicitation” (as such term is used in the rules of the Securities
and Exchange Commission (the “SEC”)) of proxies or powers of attorney or similar rights to vote, or seek to
advise or influence any Person with respect to the voting of the Covered Shares intending to facilitate any Acquisition Proposal
or cause stockholders of the Company not to vote to approve the Merger or any other transaction contemplated by the Merger Agreement.

 

(b)              
The Stockholder will immediately cease and cause to be terminated all existing discussions or negotiations with any Person
(other than the Company and its Subsidiaries) conducted heretofore with respect to any of the matters described in Section 7(a)
above.

 

(c)              
Prior to the Termination Date, and except as contemplated hereby, the Stockholder shall not (i) tender into any tender
or exchange offer, (ii) sell (constructively or otherwise), transfer, pledge, hypothecate, grant, encumber, assign or otherwise
dispose of (collectively “Transfer”), or enter into any contract, option, agreement or other arrangement or
understanding with respect to the Transfer of any of the Covered Shares or beneficial ownership or voting power thereof or therein
(including by operation of law), (iii) grant any proxies or powers of attorney, deposit any Covered Shares into a voting trust
or enter into a voting agreement with respect to any Covered Shares or (iv) knowingly take any action that would make any
representation or warranty of the Stockholder contained herein untrue or incorrect or have the effect of preventing or disabling
the Stockholder from performing its obligations under this Agreement. Any Transfer in violation of this provision shall be void.
The Stockholder further agrees to authorize and request the Company to notify the Company’s transfer agent that there is
a stop transfer order with respect to all of the Covered Shares and that this Agreement places limits on the voting of the Covered
Shares. If so requested by Parent, the Stockholder agrees that the certificates representing Covered Shares shall bear a legend
stating that they are subject to this Agreement and to the irrevocable proxy granted in Section 2(a).

 

(d)               Notwithstanding
anything to the contrary in this Agreement, the Stockholder may Transfer any or all of the Covered Shares, in accordance with
applicable Law to one or more partners or members of Stockholder or to an affiliated entity under common control with
Stockholder; provided, however, that a Transfer referred to in this sentence shall be permitted only if,
(X) as a precondition to such Transfer, the transferee agrees in a written document, reasonably satisfactory in form and
substance to Parent, to be bound by all of the terms of this Agreement, and (Y) such Transfer is effected no later than
three Business Days prior to the record date for any Stockholder Meeting (or any adjournment or postponement thereof) and
does not delay, hinder or impede (1) the timely voting of the Covered Shares in accordance with Section 1 or
(2) the consummation of the Merger.

 

    5

     

    

 

 

8.                 
Stockholder Capacity. This Agreement is being entered into by the Stockholder solely in its capacity as a stockholder
of the Company, and nothing in this Agreement shall restrict or limit the ability of any Stockholder, any of its Affiliates, or
any of their respective directors, officers or employees who is a director or officer of the Company to take any action in his
or her capacity as a director or officer of the Company to the extent specifically permitted by the Merger Agreement.

 

9.                 
Waiver of Appraisal and Dissenters’ Rights and Actions. Stockholder hereby:

 

(a)              
waives and agrees not to exercise any rights of appraisal or rights to dissent from the Merger that Stockholder may have,
and

 

(b)              
agrees (i) not to commence any claim, derivative or otherwise, against Parent, Merger Sub, the Company or any of their respective
successors, or (ii) not to commence or participate in, and to take all actions necessary to opt out of, any class in any class
action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub, the Company or any of their respective
successors, in each case of clause (i) and (ii), (A) challenging the validity of, or seeking to enjoin the operation of, any provision
of this Agreement or the Merger Agreement, (B) alleging a breach of any fiduciary duty of the Board of Directors of the Company
in connection with the Merger Agreement or the Transactions contemplated thereby, (C) making any claim with respect to SEC disclosure
(or other disclosure to the Company’s stockholders) in connection with the negotiation, execution or delivery of this Agreement
or the Merger Agreement or the approval or consummation of the Merger, or (D) making any aiding and abetting or similar claim against
Parent or Merger Sub, or any of their respective Affiliates or Representatives, in connection with the foregoing.

 

10.             
Disclosure. The Stockholder hereby authorizes Parent and the Company to publish and disclose in any announcement
or disclosure required by the SEC and in the Joint Proxy Statement the Stockholder’s identity and ownership of the Covered
Shares and the nature of the Stockholder’s obligations under this Agreement.

 

11.             
Further Assurances. From time to time, at the request of Parent and without further consideration, but without being
required to incur any cost or expense, the Stockholder shall take such further action as may reasonably be necessary or desirable
to consummate and make effective the transactions contemplated by this Agreement.

 

12.             
Non-Survival of Representations and Warranties. The representations and warranties of the Stockholders contained
herein shall not survive the closing of the transactions contemplated hereby and by the Merger Agreement.

 

13.             
Amendment and Modification. This Agreement may not be amended, modified or supplemented in any manner, whether by
course of conduct or otherwise, except by an instrument in writing specifically designated as an amendment hereto, signed on behalf
of each party and otherwise as expressly set forth herein.

 

    6

     

    

 

14.             
Waiver. No failure or delay of any party in exercising any right or remedy hereunder shall operate as a waiver thereof,
nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such
right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or
power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies which they
would otherwise have hereunder. Any agreement on the part of a party to any such waiver shall be valid only if set forth in a written
instrument executed and delivered by such party.

 

15.             
Notices. All notices and other communications hereunder shall be in writing and shall be deemed duly given (a) on
the date of delivery if delivered personally, or if by facsimile or e-mail, upon written confirmation of receipt by facsimile,
e-mail or otherwise, (b) on the first Business Day following the date of dispatch if delivered utilizing a next-day service
by a recognized next-day courier or (c) on the earlier of confirmed receipt or the fifth Business Day following the date of
mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be
delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the party
to receive such notice:

 

(i)            If to the Stockholder, to the address set forth below the Stockholder’s name on its signature page.

 

(ii)           If to Parent:

 

Assertio Therapeutics, Inc.

100 South Saunders Rd., Suite 300

Lake Forest, IL 60045

Attention:     Legal Department

Facsimile:      (510) 744-8001

E-mail:            ____________________

with a copy (which shall not constitute notice) to:

Gibson, Dunn & Crutcher LLP

555 Mission St.

San Francisco, CA 94105

Attention: Ryan A. Murr

Facsimile: (415) 393-8200

E-mail: rmurr@gibsondunn.com

 

16.             
Entire Agreement. This Agreement constitutes the entire agreement, and supersedes all prior written agreements, arrangements,
communications and understandings and all prior and contemporaneous oral agreements, arrangements, communications and understandings
between the parties with respect to the subject matter hereof.

 

17.              No
Third-Party Beneficiaries. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person
other than the parties and their respective successors and permitted assigns any legal or equitable right, benefit or remedy
of any nature under or by reason of this Agreement.

 

    7

     

    

 

18.             
Governing Law. This Agreement and all disputes or controversies arising out of or relating to this Agreement or the
transactions contemplated hereby shall be governed by, and construed in accordance with, the internal laws of the State of Delaware,
without regard to the laws of any other jurisdiction that might be applied because of the conflicts of laws principles of the State
of Delaware.

 

19.             
Submission to Jurisdiction. Each of the parties irrevocably agrees that any legal action or proceeding arising out
of or relating to this Agreement brought by any party or its Affiliates against any other party or its Affiliates shall be brought
and determined in the Court of Chancery of the State of Delaware; provided, that if jurisdiction is not then available in
the Court of Chancery of the State of Delaware, then any such legal action or proceeding may be brought in any federal court located
in the State of Delaware or any other Delaware state court. Each of the parties hereby irrevocably submits to the jurisdiction
of the aforesaid courts for itself and with respect to its property, generally and unconditionally, with regard to any such action
or proceeding arising out of or relating to this Agreement and the transactions contemplated hereby. Each of the parties agrees
not to commence any action, suit or proceeding relating thereto except in the courts described above in Delaware, other than actions
in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in Delaware as described
herein. Each of the parties further agrees that notice as provided herein shall constitute sufficient service of process and the
parties further waive any argument that such service is insufficient. Each of the parties hereby irrevocably and unconditionally
waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any action or proceeding arising
out of or relating to this Agreement or the transactions contemplated hereby, (a) any claim that it is not personally subject
to the jurisdiction of the courts in Delaware as described herein for any reason, (b) that it or its property is exempt or
immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice,
attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that
(i) the suit, action or proceeding in any such court is brought in an inconvenient forum, (ii) the venue of such suit,
action or proceeding is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such
courts.

 

20.             
Assignment; Successors. Neither this Agreement nor any of the rights, interests or obligations under this Agreement
may be assigned or delegated, in whole or in part, by operation of law or otherwise, by any party without the prior written consent
of the other parties, and any such assignment without such prior written consent shall be null and void; provided, however,
that Parent and Merger Sub may assign, in its sole discretion, any or all of its rights, interests and obligations under this Agreement
to Parent or any of its Affiliates at any time, in which case all references herein to Parent or Merger Sub, as applicable, shall
be deemed references to such other Affiliate, except that all representations and warranties made herein with respect to Parent
or Merger Sub as of the date of this Agreement shall be deemed to be representations and warranties made with respect to such other
Affiliate as of the date of such assignment. Subject to the preceding sentence, this Agreement will be binding upon, inure to the
benefit of, and be enforceable by, the parties and their respective successors and assigns.

 

    8

     

    

 

21.             
Enforcement. The parties agree that irreparable damage would occur in the event that the parties hereto do not perform
the provisions of this Agreement in accordance with its terms or otherwise breach such provisions. Accordingly, prior to the Termination
Date, the parties acknowledge and agree that each party shall be entitled to an injunction, specific performance and other equitable
relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the Court of Chancery
of the State of Delaware, provided, that if jurisdiction is not then available in the Court of Chancery of the State of
Delaware, then in any federal court located in the State of Delaware or any other Delaware state court, this being in addition
to any other remedy to which such party is entitled at law or in equity. Each of the parties hereby further waives (a) any
defense in any action for specific performance that a remedy at law would be adequate and (b) any requirement under any law
to post security as a prerequisite to obtaining equitable relief.

 

22.             
Severability. Whenever possible, each provision or portion of any provision of this Agreement shall be interpreted
in such manner as to be effective and valid under applicable Law, but if any provision or portion of any provision of this Agreement
is held to be invalid, illegal or unenforceable in any respect under any applicable Law or rule in any jurisdiction, such invalidity,
illegality or unenforceability shall not affect any other provision or portion of any provision in such jurisdiction, and this
Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision
or portion of any provision had never been contained herein.

 

23.             
Waiver of Jury Trial. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY
IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

24.             
Counterparts. This Agreement may be executed in two or more counterparts, all of which shall be considered one and
the same instrument and shall become effective when one or more counterparts have been signed by each of the parties and delivered
to the other party.

 

25.             
Facsimile or .pdf Signature. This Agreement may be executed by facsimile or .pdf signature and a facsimile or .pdf
signature shall constitute an original for all purposes.

 

26.             
Confidentiality. The Stockholders agree (a) to hold any non-public information regarding this Agreement and
the Merger in strict confidence and (b) except as required by law or legal process not to divulge any such non-public information
to any third Person.

 

27.             
No Presumption Against Drafting Party. Each of the parties to this Agreement acknowledges that it has been represented
by counsel in connection with this Agreement and the transactions contemplated by this Agreement. Accordingly, any rule of law
or any legal decision that would require interpretation of any claimed ambiguities in this Agreement against the drafting party
has no application and is expressly waived.

 

[The remainder of this page is intentionally
left blank.]

 

    9

     

    

 

IN WITNESS WHEREOF, Parent and the Stockholders
have caused to be executed or executed this Agreement as of the date first written above.

 

	 	ALLIGATOR ZEBRA HOLDINGS, INC.
	 	 
	 	Name:
	 	Title:
	 	 
	 	STOCKHOLDER: 
	 	 
	 	By:	
	 	 	Name:
	 	 	Title:

 

Signature Page to Voting
Agreement

 

    

     

    

 

SCHEDULE A

 

	Stockholder 	Address	Covered Shares
	 	 	 
	 	 	 

 

Schedule A

1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}]]